Greenwich Lifesciences Inc (GLSI)

Greenwich Lifesciences Inc Azioni (GLSI) Dati Finanziari

Conto economico

Trimestrale

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	-	-	-	-	-
Operating Expenses	10.54% 2.5372	2.836	2.5029	1.7478	2.2411
Operating Income/Loss	10.54% -2.5372	-2.836	-2.5029	-1.7478	-2.2411
Income/Loss From Continuing Operations Before Tax	9.96% -2.4732	-2.7467	-2.3918	-1.6284	-2.1249
Income/Loss From Continuing Operations After Tax	9.96% -2.4732	-2.7467	-2.3918	-1.6284	-2.1249
Net Income/Loss	9.96% -2.4732	-2.7467	-2.3918	-1.6284	-2.1249
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	12.86	-	-	-	-
Diluted Average Shares	12.86	-	12.85	12.85	-
Basic Earnings Per Share	9.52% -0.19	-0.21	-0.19	-0.13	-0.17
Diluted Earnings Per Share	9.52% -0.19	-0.21	-0.19	-0.13	-0.16
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-